11.07.2015 Views

to download the publication - National Drug Authority(U)

to download the publication - National Drug Authority(U)

to download the publication - National Drug Authority(U)

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

i. An authorisation or clearance may be given.ii. A query may arise whereby <strong>the</strong> consignment may be held pending fur<strong>the</strong>r investigations.iii. An outright rejection of <strong>the</strong> consignment pending re-export or destruction at owners’ expensemay be issued.GUIDANCE ON VERIFICATION OF SPECIAL DRUG IMPORTS1. EligibilityPharmacies (retail or wholesale)Hospitals (Government or NGO)Government and Private institutions involved in providing healthcare and/or researchMedical or Veterinary NGOsIndividual patients or <strong>the</strong>ir representatives** For a named patient supported with a valid prescription2. Criteriaa. <strong>Drug</strong>s which are on <strong>the</strong> Essential <strong>Drug</strong>s List for Uganda (EDLU/EVDLU) for which <strong>the</strong>re are no registeredequivalentsb. Life-saving drugs for which <strong>the</strong>re are no registered equivalentsc. O<strong>the</strong>r drugs <strong>the</strong> registered equivalents of which are currently unavailable on <strong>the</strong> market (as verified by NDA orany o<strong>the</strong>r reasonable method)d. <strong>Drug</strong>s registered by o<strong>the</strong>r stringent <strong>Drug</strong> regula<strong>to</strong>ry authorities as approved by NDA after written request andjustification.- Preferred sources of <strong>the</strong> unregistered drugs shall be those with o<strong>the</strong>r products on <strong>the</strong> <strong>Drug</strong>s Register, whoseGMP status has been approved by NDA.- O<strong>the</strong>r drug sources may be approved by NDA under exceptional circumstances on presentation of sufficientjustification, such as, but not limited <strong>to</strong>, approval of registration and/or current GMP status by a stringent<strong>Drug</strong> Regula<strong>to</strong>ry <strong>Authority</strong> or approval of GMP status by NDA.No product shall be approved under <strong>the</strong>se provisions if its registration has been voluntarilywithdrawn and/or denied or revoked for safety, efficacy and quality reasons, including, but notlimited <strong>to</strong>, failure <strong>to</strong> comply with current GMP.3. ProcedureA form for application for special drug import must be completed for each drug product applied for(obtainable at NDA).Save <strong>the</strong> above criteria, <strong>the</strong> normal procedure for processing applications for verification shall apply.Exemption:A letter authorizing <strong>the</strong> import of drugs for personal use shall be granted after submission of an application<strong>to</strong>ge<strong>the</strong>r with a valid prescription up <strong>to</strong> six months.GUIDANCE FOR APPLICATION OF VERIFICATION FEES1. Applicabilitya) A Pro-forma Invoice Verification Fee of 2.0% of <strong>the</strong> Free On Board (FOB) value of <strong>the</strong> PFI will be chargedon all imports subject <strong>to</strong> NDA import regulation with <strong>the</strong> exception of those listed in section 2 below.b) Verification fees are payable by <strong>the</strong> importer.c) Free goods accompanying similar commercial goods shall be subject <strong>to</strong> 2.0% PFI-VF and shall beassumed <strong>to</strong> be priced similarly <strong>to</strong> <strong>the</strong> accompanying commercial goods for <strong>the</strong> purpose of calculation ofPFI-VF.3


d) Donations and Medical supplies with no declared commercial value procured by community-based NGOsas identified and duly authorised by <strong>the</strong> NDA will be subject <strong>to</strong> a flat verification fee of UGX 50,000 perPFI (this is in addition <strong>to</strong> <strong>the</strong> provisional import permit fee of UGX 100,000).e) Donations <strong>to</strong> commercial entities like private clinics, pharmacies and hospitals must declare <strong>the</strong> actualvalue and shall attract a PFI-VF of 2.0%.f) The PFI-VF of 2.0% for donations <strong>to</strong> Government ministries, Institutions or projects by identified reliefagencies, which are exempted by International/<strong>National</strong> laws/agreements from paying fees shall be paidby <strong>the</strong> recipient ministry, institution of project.2. ExemptionsThe following categories of medicinal items will not be subject <strong>to</strong> PFI-VF:a) Vaccines and related supplies for public goodb) Veterinary Vaccines and related supplies categorised by <strong>the</strong> Direc<strong>to</strong>r of Animal Resources, Ministry ofAgriculture, Animal Industry and Fisheries (MAAIF), as for <strong>the</strong> public goodc) Pharmaceutical raw materials and packaging materials imported by licensed pharmaceuticalmanufacturersd) Any item ordered in non-commercial quantities for a named patient on <strong>the</strong> basis of a valid prescriptione) O<strong>the</strong>r items or importers exempted by <strong>the</strong> NDA from time <strong>to</strong> time after written request and justification.3. Payment termsa) Payment shall be in full at <strong>the</strong> time of application for verification of <strong>the</strong> PFI. Verification of a PFI may notbe authorised until and unless full payment of <strong>the</strong> fee has been made.b) All payments of PFI-VF shall be paid through <strong>the</strong> bank based on an invoice issued by <strong>the</strong> accountssection of NDA.c) Evidence of payment of PFI-VF in form of an au<strong>the</strong>ntic banking slip must be presented <strong>to</strong> accountssection of NDA shall issue a corresponding receipt <strong>to</strong> <strong>the</strong> payer/importer.d) Note: In <strong>the</strong> case of MOH (and related institutions/Programmes/Projects), NMS, JMS and any o<strong>the</strong>rimporter approved by NDA, each application shall be invoiced but payments may be made on <strong>the</strong> basisof one month credit line or any o<strong>the</strong>r arrangement approved by NDA.e) A receipt or invoice in <strong>the</strong> case of importer using a credit line shall be attached <strong>to</strong> <strong>the</strong> application for aVerification Certificate as <strong>the</strong> only acceptable evidence of payment or commitment <strong>to</strong> pay <strong>the</strong> PFI-VF Annual import permit…………………………………..shs.300,000 Provisional import/export permit……………………...shs.100,000 A booklet of applications for verification……………….shs.10,000 Verification fees………………………………………2% FOB valueRE-EXPORT OF REJECTED CONSIGNMENTS1. <strong>Drug</strong>s rejected for quality reasons must be re-exported <strong>to</strong> <strong>the</strong> supplier in <strong>the</strong> country of export within astipulated period of one month after receiving a rejection report.2. <strong>Drug</strong>s rejected due <strong>to</strong> being unregistered in Uganda or neutral labelling may be re-exported <strong>to</strong> a thirdcountry on special request with special clearance from <strong>the</strong> authorities of <strong>the</strong> importing country.4


RE-EXPORT PROCEDURE1. Application for verification is lodged in by intending exporter, accompanied by <strong>the</strong> relevant invoice anddocuments related <strong>to</strong> <strong>the</strong> rejection indicating also <strong>the</strong> exact point of destination.2. Re-inspection is carried out by an inspec<strong>to</strong>r of drugs <strong>to</strong> confirm that <strong>the</strong> consignment is still intact, beforea provisional re-export permit is issued by NDA on payment of <strong>the</strong> appropriate fee.3. A cus<strong>to</strong>ms or NDA official must witness loading for re-export.4. Copies of <strong>the</strong> re-export documents stamped at exit ports must be submitted <strong>to</strong> NDA as proof of RE-EXPORT.REGULAR EXPORT OF DRUGSThis can only be done by licensed pharmacies or manufacturers of drugs in accordance with section 45 of NDP/AAct Cap 2006. Where <strong>the</strong> exporter has no annual export permit a provisional export permit is issued perconsignment after:I. Presentation of <strong>the</strong> following documents;a) Order from importerb) Copy of <strong>the</strong> authority given <strong>to</strong> importer by competent authority in country of importc) 3 copies of a proforma invoice prepared by exporter showing batch numbers, registration status of<strong>the</strong> products <strong>to</strong> be exported and quantities of drugs <strong>to</strong> be exported.d) Application for both a provisional export permit, where applicable, and verification certificate.II. Payment of <strong>the</strong> appropriate fees.III. NDA may from time <strong>to</strong> time decide which consignment is <strong>to</strong> be inspected before re-export.The word drug in <strong>the</strong>se guidelines refers <strong>to</strong> all human and veterinary medicines, biologicals, syringes, medicalsundries, labora<strong>to</strong>ry reagents and o<strong>the</strong>r diagnostic equipments.These guidelines also apply in <strong>the</strong> importation of public health chemicals, condoms, mosqui<strong>to</strong> nets and any o<strong>the</strong>rsubstance as <strong>the</strong> authority may deem necessary.Note:a) Manda<strong>to</strong>ry analysis is conducted on every batch of condoms imported in<strong>to</strong> <strong>the</strong> country.b) For drug donations see fur<strong>the</strong>r guidance on guidelines for drug donationsc) <strong>National</strong> <strong>Drug</strong> <strong>Authority</strong> reserves <strong>the</strong> right <strong>to</strong> approve or reject any application for importation or exportation of adrug in line with its mandate.5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!